Literature DB >> 23246934

Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease.

Kathryn V Papp1, Peter J Snyder, James A Mills, Kevin Duff, Holly J Westervelt, Jeffrey D Long, Spencer Lourens, Jane S Paulsen.   

Abstract

Executive dysfunction (ED) is a characteristic of Huntington disease (HD), but its severity and progression is less understood in the prodromal phase, e.g., before gross motor abnormalities. We examined planning and problem-solving abilities using the Towers Task in HD mutation-positive individuals without motor symptoms (n = 781) and controls (n = 212). Participants with greater disease progression (determined using mutation size and current age) performed more slowly and with less accuracy on the Towers Task. Performance accuracy was negatively related to striatal volume while both accuracy and working memory were negatively related to frontal white matter volume. Disease progression at baseline was not associated with longitudinal performance over 4 years. Whereas the baseline findings indicate that ED becomes more prevalent with greater disease progression in prodromal HD and can be quantified using the Towers task, the absence of notable longitudinal findings indicates that the Towers Task exhibits limited sensitivity to cognitive decline in this population.

Entities:  

Mesh:

Year:  2012        PMID: 23246934      PMCID: PMC3569950          DOI: 10.1093/arclin/acs105

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  28 in total

1.  Structural MR image processing using the BRAINS2 toolbox.

Authors:  Vincent A Magnotta; Greg Harris; Nancy C Andreasen; Daniel S O'Leary; William T C Yuh; Dan Heckel
Journal:  Comput Med Imaging Graph       Date:  2002 Jul-Aug       Impact factor: 4.790

2.  Planning and spatial working memory following frontal lobe lesions in man.

Authors:  A M Owen; J J Downes; B J Sahakian; C E Polkey; T W Robbins
Journal:  Neuropsychologia       Date:  1990       Impact factor: 3.139

3.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

Review 4.  Biological markers of cognition in prodromal Huntington's disease: a review.

Authors:  Kathryn V Papp; Richard F Kaplan; Peter J Snyder
Journal:  Brain Cogn       Date:  2011-09-01       Impact factor: 2.310

5.  Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.

Authors:  Alexander Peinemann; Sabine Schuller; Córina Pohl; Thomas Jahn; Adolf Weindl; Jan Kassubek
Journal:  J Neurol Sci       Date:  2005-09-26       Impact factor: 3.181

6.  Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.

Authors:  V Hahn-Barma; B Deweer; A Dürr; C Dodé; J Feingold; B Pillon; Y Agid; A Brice; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

7.  Effects of depression on working memory in presymptomatic Huntington's disease.

Authors:  C Nehl; R E Ready; J Hamilton; J S Paulsen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

8.  Profile of cognitive progression in early Huntington's disease.

Authors:  A K Ho; B J Sahakian; R G Brown; R A Barker; J R Hodges; M-N Ané; J Snowden; J Thompson; T Esmonde; R Gentry; J W Moore; T Bodner
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

9.  A brief assessment of executive control dysfunction: discriminant validity and homogeneity of planning, set shift, and fluency measures.

Authors:  K R Hanes; D G Andrewes; D J Smith; C Pantelis
Journal:  Arch Clin Neuropsychol       Date:  1996       Impact factor: 2.813

Review 10.  Future directions in research with presymptomatic individuals carrying the gene for Huntington's disease.

Authors:  Nellie Georgiou-Karistianis; Eleanor Smith; John L Bradshaw; Phyllis Chua; John Lloyd; Andrew Churchyard; Edmond Chiu
Journal:  Brain Res Bull       Date:  2003-01-30       Impact factor: 4.077

View more
  9 in total

1.  The BACHD Rat Model of Huntington Disease Shows Signs of Fronto-Striatal Dysfunction in Two Operant Conditioning Tests of Short-Term Memory.

Authors:  Erik Karl Håkan Clemensson; Laura Emily Clemensson; Olaf Riess; Huu Phuc Nguyen
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 2.  Progress in Huntington's disease: the search for markers of disease onset and progression.

Authors:  Sarah Mason; Roger A Barker
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

3.  Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.

Authors:  Mandi Musso; Holly James Westervelt; Jeffrey D Long; Erin Morgan; Steven Paul Woods; Megan M Smith; Wenjing Lu; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2015-01       Impact factor: 2.892

4.  Everyday cognition in prodromal Huntington disease.

Authors:  Janet K Williams; Ji-In Kim; Nancy Downing; Sarah Farias; Deborah L Harrington; Jeffrey D Long; James A Mills; Jane S Paulsen
Journal:  Neuropsychology       Date:  2014-07-07       Impact factor: 3.295

5.  Executive functions in premanifest Huntington's disease.

Authors:  S Christine You; Michael D Geschwind; Sharon J Sha; Alexandra Apple; Gabriella Satris; Kristie A Wood; Erica T Johnson; Jonathan Gooblar; Jeanne S Feuerstein; Steven Finkbeiner; Gail A Kang; Bruce L Miller; Christopher P Hess; Joel H Kramer; Katherine L Possin
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

6.  Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.

Authors:  Maria B Misiura; Spencer Lourens; Vince D Calhoun; Jeffrey Long; Jeremy Bockholt; Hans Johnson; Ying Zhang; Jane S Paulsen; Jessica A Turner; Jingyu Liu; Betul Kara; Elizabeth Fall
Journal:  J Int Neuropsychol Soc       Date:  2017-02       Impact factor: 2.892

7.  Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease.

Authors:  Deborah L Harrington; Dawei Liu; Megan M Smith; James A Mills; Jeffrey D Long; Elizabeth H Aylward; Jane S Paulsen
Journal:  Brain Behav       Date:  2013-11-13       Impact factor: 2.708

8.  Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.

Authors:  Jane S Paulsen; Jeffrey D Long; Hans J Johnson; Elizabeth H Aylward; Christopher A Ross; Janet K Williams; Martha A Nance; Cheryl J Erwin; Holly J Westervelt; Deborah L Harrington; H Jeremy Bockholt; Ying Zhang; Elizabeth A McCusker; Edmond M Chiu; Peter K Panegyres
Journal:  Front Aging Neurosci       Date:  2014-04-22       Impact factor: 5.750

9.  Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington's Disease.

Authors:  Maria B Misiura; Jennifer Ciarochi; Jatin Vaidya; Jeremy Bockholt; Hans J Johnson; Vince D Calhoun; Jane S Paulsen; Jessica A Turner
Journal:  J Int Neuropsychol Soc       Date:  2019-02-26       Impact factor: 2.892

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.